Eupraxia Pharmaceuticals Inc. (EPRX.TO) - Stock Prices, Stock Peers & Analysis

Home
EPRX.TO

Company Name	Eupraxia Pharmaceuticals Inc.
Symbol	EPRX.TO
Currency	CAD
Price	3.7
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	131,803,620
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	3.25 - 8.46
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. James A. Helliwell FRCPC, M.D.
Website	https://www.eupraxiapharma.com

An error occurred while fetching data.

About Eupraxia Pharmaceuticals Inc.

Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidate is EP-104IAR, which is in a Phase II clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis,